SEER Inquiry System - Question 20041033 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 11/24/2024 3:21 PM

Question 20041033

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

CAP Protocol, Bone Marrow, 13. www.cap.org, Jan 2004

Question:

Histology--Hematopoietic, NOS: When the histology is described in both WHO and FAB terms, which terminology has priority to code this field? See Discussion.

Discussion:

Example: Bone marrow biopsy was reported as: "Markedly hypercellular marrow aspirate with myelodysplastic alterations morphologically consistent with refractory anemia (FAB) or refractory cytopenia with multilineage dysplasia (WHO)."

Answer:

For cases diagnosed prior to 1/1/2010:Give preference to the WHO terminology when both are used in the final pathology diagnosis. The WHO classification of tumors is the current standard and is recommended by the College of American Pathologists.

For cases diagnosed 2010 forward, refer to the Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual and the Hematopoietic Database (Hematopoietic DB) provided by SEER on its website to research your question. If those resources do not adequately address your issue, submit a new question to SINQ.

Cancer Site Category:

N/A

Data Item Category:

Histology

Other Category:

N/A

Year:

2004